Archives of Toxicology

, Volume 55, Issue 2, pp 110–118 | Cite as

Estrogen-induced tumorigenesis in hamsters: roles for hormonal and carcinogenic activities

  • Jonathan J. Li
  • Sara Antonia Li
Original Investigations


Based on the experimental studies presented herein, we have concluded there are hormonal and carcinogenic aspects to estrogens, both natural and synthetic, which are involved in renal tumorigenesis in the hamster. Hormonal aspects related to this tumor system are based on the presence of specific estrogen receptor in the untransformed kidney which is elevated by prolonged estrogen treatment. Moreover, antiestrogens, which inhibit estrogen receptor complex binding activity, completely block renal tumor induction by estrogens. Finally, estrogens were found to induce progesterone receptor in the hamster kidney and this induction can be inhibited by androgens and antiestrogens. Carcinogenic aspects related to renal tumorigenesis are suggested by the marked suppression of estrogen-induced kidney tumors by α-naphthoflavone. In addition, ethinyl estradiol, as potent an estrogen in the hamster as either DES of 17β-estradiol, induced only a very low renal tumor incidence. The finding that aryl hydrocarbon hydroxylase activity in the hamster kidney, but not the liver, is depressed markedly by estrogens and enhanced by androgenic hormone suggests involvement of the microsomal monooxygenase system in affecting estrogen metabolism and ultimately perhaps its carcinogenicity.

Key words

Estrogen Tumorigenesis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Antonio P, Gabaldon M, Lacomba T, Juan A (1974) Effect of the antiestrogen nafoxidine on the occurrence of estrogen-dependent renal tumors in hamster Horm Metab Res 6: 552–524Google Scholar
  2. Greenwald P, Barolom JJ, Nasca PC (1971) Vaginal cancer after maternal treatment with synthetic estrogens. N Engl J Med 285: 390–392Google Scholar
  3. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130–7139Google Scholar
  4. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina: Association of maternal stilbesterol therapy with tumor appearance on young women. N Eng J Med 284: 878–881Google Scholar
  5. Himmelhoch SR, Evans WH, Mage MG, Peterson EA (1969) Purification of myeloperoxidases from the bone marrow of the guinea pig. Biochemistry 8: 914–921Google Scholar
  6. Hoffman AR, Paul SM, Axelrod J (1980) Estrogen-2-hydroxylase in the rat. Distribution and response to hormonal modification. Biochem Pharmacol 29: 83–87Google Scholar
  7. Holtzman JL, Rumack BH, Erickson RR (1976) Spectrophotometric and radiometric studies on the in vivo binding of phenobarbital to hepatic microsomes. Arch Biochem Biophys 173: 710–719Google Scholar
  8. Hoover R, Glass A, Finkle WD, Azavedo D, Milne K (1981) Conjugated estrogen and breast cancer risk in women. J Natl Cancer Inst 67: 815–820Google Scholar
  9. Horning EC, Thenot J-P, Helton ED (1978) Toxic agents resulting from the oxidative metabolism of steroid hormone and drugs. J Toxicol Environ Health 4: 341–361Google Scholar
  10. Kirkman H (1959) Estrogen-induced tumors of the kidney in Syrian hamsters. Natl Cancer Inst Monogr 1: 1–59Google Scholar
  11. Klicka JK, Li SA, Li JJ (1983) Influence of estrogens on peroxidase activity in the Syrian hamster liver, kidney, and renal carcinoma. Biochem Pharmacol 32: 497–502Google Scholar
  12. Korach K, Metzler M, Mclachan JA (1978) Estrogenic activity in vivo and in vitro of some diethylstilbestrol. Proc Natl Acad Sci USA 75: 468–471Google Scholar
  13. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680–685Google Scholar
  14. Li JJ, Kirkman H, Hunter R (1969) Sex difference and gonadal hormone influence on Syrian hamster kidney esterase isozymes. J Histochem Cytochem 17: 386–393Google Scholar
  15. Li JJ, Talley D, Li SA, Villee C (1974) An estrogen binding protein in the renal cytosol of the intact, castrated, and estrogenized golden hamster. Endocrinology 96: 1106–1113Google Scholar
  16. Li JJ, Cuthbertson TL, Li SA (1977) Specific androgen binding in the kidney and estrogen-dependent renal carcinoma of the Syrian hamster. Endocrinology 101: 1006–1015Google Scholar
  17. Li SA, Li JJ (1978) An estrogen-induced progesterone receptor in the Syrian hamster kidney. I Modulation by antiestrogens and androgens. Endocrinology 103: 2119–2128Google Scholar
  18. Li JJ, Cuthbertson TL, Li SA (1980) Inhibition of estrogen carcinogenesis in the Syrian golden hamster kidney by antiestrogens. J Natl Cancer Inst 64: 795–800Google Scholar
  19. Li JJ, Li SA (1981a) Estrogen-induced progesterone receptor in the Syrian hamster kidney. II. Modulation by synthetic progestins. Endocrinology 108: 1751–1756Google Scholar
  20. Li JJ, Li SA (1981b) Inhibition of estrogen-induced renal tumorigenesis in the Syrian golden hamster by BHA, β- and α-naphthoflavone. Proc Assoc Cancer Res 22: 11Google Scholar
  21. Li SA, Li JJ (1981) Changes in estrogen receptor levels during DES-induced hepatocarcinogenesis in the Syrian hamster fed α-naphthoflavone. J Steroid Biochem 15: 387–392Google Scholar
  22. Li SA, Lam LKP, Li JJ (1983) Effect of steroid hormone treatment on aryl hydrocarbon hydroxylase activity in the Syrian hamster kidney. Biochem Pharmacol 32: 2847–2850Google Scholar
  23. Lutz WK, Jaggi W, Schlatter CH (1982) Covalent binding of diethylstilbestrol to DNA in rat and hamster liver and kidney. Chem Biol Interact 42: 251–257Google Scholar
  24. Lyon FA (1975) The development of adenocarcinoma of the endometrium in young women receiving long term sequential oral contraception. Am J Obstet Gynecol 123: 299–302Google Scholar
  25. Metzler M (1981a) Studies on the mechanism of carcinogenicity of diehtylstilbestrol: Role of metabolic activation. Food Cosmet Toxicol 19: 611–615Google Scholar
  26. Metzler M (1981b) The metabolism of diethylstilbestrol. CRC Crit Rev Biochem 10: 171–212Google Scholar
  27. Nawate H, Yamamoto RS, Poirier LA (1981) Elevated levels of ornithine decarboxylase and polyamines in the kidneys of estradiol-treated male hamsters. Carcinogenesis 2: 1207–1211Google Scholar
  28. Nissen ED, Kent DR (1975) Liver tumors and oral contraceptives. Obstet Gynecol 46: 460–467Google Scholar
  29. Pederson TC, Buege JA, Aust SD (1973) Microsomal electron transport: the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase in liver microsomal lipid peroxidation. J Biol Chem 248: 7134–7141Google Scholar
  30. Purdy RH, Moore PH, Williams MC, Goldzieher JW, Paul SM (1982) Relative rates of 2- and 4-hydroxyestrogen synthesis are dependent on both substrate and tissue. FEBS Lett 138: 40–44Google Scholar
  31. Schellenberg KA, Hellerman L (1958) Oxidation of reduced pyridine nucleotide. J Biol Chem 237: 547–557Google Scholar
  32. Shar SR, Kew MC (1982) Oral contraceptives and hepatocellular carcinoma. Cancer 49: 407–410Google Scholar
  33. Silverberg SG, Makowski EL (1975) Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol 46: 503–506Google Scholar
  34. Smith DC, Prentice RL, Bauermeister DE (1981) Endometrial carcinoma: Histophatology, survival and exogenous estrogens. Gynecol Obstet Invest 12: 169–179Google Scholar
  35. Sparinins VL, Wattenberg LW (1981) Enhancement of glutathione-S-transferase activity of the mouse forestomach by inhibitors of benzo(a)pyrene-induced neoplasia of the forestomach. J Natl Cancer Inst 66: 769–771Google Scholar
  36. Stern E, Clark VA, Coffelt CF (1970) Contraceptives and dysplasia:Higher rate for pill choosers. Science 169: 497–498Google Scholar
  37. Tanka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG (1980) A new sensitive and specific bioassay for lactogenic hormones: Measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 51: 1058–1063Google Scholar
  38. Tsibris JCM, McGuire PM (1977) Microsomal activation and binding to nucleic acids and proteins. Biochem Biophys Res Commun 78: 411–417Google Scholar
  39. Vana J, Murphy GP, Aronoff BL, Baker HW (1979) Survey of primary liver tumors and oral contraceptive use. J Toxicol Environ Health 5: 255–273Google Scholar
  40. Wattenberg LW, Leong JL, Strand PJ (1962) Benzopyrene hydroxylase activity in the gastrointestinal tract. Cancer Res 22: 1120–1125Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Jonathan J. Li
    • 1
    • 2
  • Sara Antonia Li
    • 1
    • 2
  1. 1.Medical Research LaboratoriesVeterans Administration Medical CenterMinneapolis
  2. 2.Department of Urologic SurgeryUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations